News

Alm. Brand A/S Shares Buyback Program Insights and Updates

Alm. Brand A/S Shares Buyback Program Insights and Updates

Overview of Alm. Brand A/S Share Buyback Program

Alm. Brand A/S, a prominent player in the financial sector, recently initiated a noteworthy share buyback program valued at up to DKK 835.2 million. This move, announced in accordance with company guidelines, aims to reinforce investor confidence and enhance shareholder returns.

Latest Transaction Analysis

As part of the buyback initiative, Alm. Brand A/S undertook several transactions from April 28 to May 2, 2025. The specifics of these transactions paint a clear picture of the company’s strategic approach in a competitive market environment.

Week 18 Transactions

During week number 18, Alm. Brand A/S made significant progress under the buyback program. A total of 1,300,000 shares were acquired, amounting to a total expenditure of DKK 20,050,800. Below is a detailed summary of the shares bought during this period:

Transaction Details

Starting with an accumulated total of 8,870,000 shares, the transactions included:

  • April 28, 2025: 250,000 shares at an average price of DKK 15.38
  • April 29, 2025: 250,000 shares at an average price of DKK 15.40
  • April 30, 2025: 260,000 shares at an average price of DKK 15.59
  • May 1, 2025: 260,000 shares at an average price of DKK 15.38
  • May 2, 2025: 280,000 shares at an average price of DKK 15.37

This diligent buying reflects Alm. Brand A/S’s commitment to protecting and enhancing shareholder value amidst fluctuating market conditions.

Accumulated Buyback Summary

As of the latest transactions, Alm. Brand A/S holds a remarkable total of 10,170,000 shares, which accounts for approximately 6.72% of all outstanding shares. This bold strategy underscores the company's intent to assert its presence in the market and demonstrates a proactive approach towards capital management.

Implications for Investors

For investors and market analysts, these share buybacks serve as a signal of financial strength and a positive outlook for the future. This program not only provides immediate financial benefits to shareholders but also enhances the company's earnings per share metrics by reducing the total number of shares outstanding.

Contact Information for Inquiries

If you have any questions or require further details regarding the buyback program, you are encouraged to reach out to:

Mads Thinggaard
Head of Investor Relations & ESG
Mobile: +45 2025 5469

Frequently Asked Questions

What is the purpose of the share buyback program?

The share buyback program aims to strengthen investor confidence, enhance shareholder returns, and manage capital effectively.

How many shares were bought back in week 18?

A total of 1,300,000 shares were bought back during week number 18.

What has the total shareholding reached after the recent transactions?

Alm. Brand A/S now holds 10,170,000 shares, which is 6.72% of the total outstanding shares.

Who can be contacted for more information about the buyback program?

Investors can contact Mads Thinggaard, the Head of Investor Relations & ESG, at +45 2025 5469 for inquiries.

What are the benefits of share buybacks for shareholders?

Share buybacks can increase earnings per share, enhance the company's stock price, and provide immediate financial returns to shareholders.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 14

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 20

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 19

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 22

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 24

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 20

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 24

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 20

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 15

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Fortunoff Backyard Store Expands in Northern Virginia Market

Updated Category News Views 142

Fortunoff Backyard Store expanded into Northern Virginia back in early 2024, marking a significant milestone as their 30th location. Traders were eyeing this move closely—retail expansion often signals confidence in consumer spending. But did they overextend? That’s the big question. This latest store, nestled in Woodbridge, occupies over 18,000 square feet and is...

Continue Reading
First Sentier Investors Implements Nature Targets for Sustainability

Updated Category News Views 97

First Sentier Investors Sets Its First Nature Targets First Sentier Investors, a prominent global investment management firm, has announced its initial nature targets as part of its commitment to the Taskforce on Nature-related Financial Disclosures (TNFD). This initiative is aligned with their ongoing efforts to incorporate sustainability into their investment strategy...

Continue Reading
Hivemapper's Bee Maps: Transforming the Future of Mapping

Updated Category News Views 296

Hivemapper's Bee Maps: A Revolutionary Approach to Mapping Today marks an exciting change in the mapping industry with the launch of Bee Maps by Hivemapper Inc. Known for driving the world’s fastest-growing street-level mapping initiative, Hivemapper is committed to improving map accuracy and accessibility through its innovative technology. What is Bee Maps? Bee Maps is...

Continue Reading
Latham Group's Stock Target Rises: A Positive Outlook Ahead

Updated Category News Views 92

Stifel Holds a Positive View on Latham Group Inc. Stifel has recently reaffirmed its Buy rating for Latham Group Inc. (NASDAQ:SWIM) and bumped its price target to $7.00, up from the previous $6.80. This decision is fueled by upcoming investor meetings led by Latham Group's CEO, Scott Rajeski, and CFO, Oliver Gloe. These meetings aim to provide crucial insights into the...

Continue Reading
Banking Stocks Surge: Future Potential and What Lies Ahead

Updated Category News Views 110

Banking Stocks High Performance Amid AI Dominance The financial sector has shown remarkable resilience this year, despite artificial intelligence (AI) capturing much of the media attention. Bank stocks have emerged as leaders in market performance, highlighted through the Financial Select Sector SPDR ETF reaching new all-time highs. This upward trend occurred even as the...

Continue Reading